Ron Senator files SEC Form 4 disclosures for NeurogesX Inc. They have made 6 open-market trades across 1 company since 2011, most recently 2011-08-10.
CIK 0001496202
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NGSX | 82,109 | — |
Shares reported on the most recent Form 4, priced at the 2011-08-11 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NGSX | SELL | 2011-08-09 | 2011-08-11 | $2.07 | $339K | N/A | N/A | N/A |
| NGSX | SELL | 2011-06-24 | 2011-06-28 | $2.10 | $18K | N/A | N/A | N/A |
| NGSX | SELL | 2011-06-23 | 2011-06-27 | $2.09 | $105K | N/A | N/A | N/A |
| NGSX | SELL | 2011-06-16 | 2011-06-23 | $3.14 | $1.3M | N/A | N/A | N/A |
| NGSX | SELL | 2011-06-02 | 2011-06-06 | $2.34 | $49K | N/A | N/A | N/A |
| NGSX | SELL | 2011-02-28 | 2011-03-02 | $3.67 | $52K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.